Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
2370 On Other Exchanges
Symbol
Exchange
2370 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

medinet co ltd (2370) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MEDINET CO LTD (2370)

Related News

No related news articles were found.

medinet co ltd (2370) Related Businessweek News

No Related Businessweek News Found

medinet co ltd (2370) Details

MEDINET Co., Ltd. provides immuno-cell therapy total support services to medical institutions for conducting cancer immuno-cell therapy in Japan. The company’s immuno-cell therapy total support services include the provision of design, layout, installation, and operation management of cell processing facilities; biotechnology for cell culture and processing, and know-how for quality control; cell engineers for cell processing and quality check; materials, reagents, and consumables supply services; and custom-made medical practice management system. Its technology pipeline comprises dendritic cell vaccine therapy, natural killer-cell therapy, gamma-delta T-cell therapy, alpha-beta T-cell therapy, and cytotoxic T-lymphocyte therapy. The company was founded in 1995 and is headquartered in Yokohama, Japan.

164 Employees
Last Reported Date: 12/18/14
Founded in 1995

medinet co ltd (2370) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

medinet co ltd (2370) Key Developments

MEDINET Co., Ltd. Presents at BIO-Europe Spring 2015, Mar-09-2015 through Mar-11-2015

MEDINET Co., Ltd. Presents at BIO-Europe Spring 2015, Mar-09-2015 through Mar-11-2015. Venue: Paris Expo - Porte de Versailles, Hall 5, Paris, France. Presentation Date & Speakers: Mar-09-2015, Kunihiko Suzuki, Member of the Board, Chief Business Officer.

MEDINET Co., Ltd. Reports Consolidated Earnings Results for the First Quarter Ended December 31, 2014; Provides Earnings Guidance for the Fiscal Year Ending September 2015

MEDINET Co., Ltd. reported consolidated earnings results for the first quarter ended December 31, 2014. For the quarter, the company reported net sales of ¥408,674,000 against ¥526,769,000 a year ago. Operating loss was ¥433,422,000 against ¥287,269,000 a year ago. Ordinary loss was ¥293,800,000 against ¥272,936,000 a year ago. Loss before income taxes was ¥294,090,000 against ¥280,590,000 a year ago. Loss before minority interests was ¥296,682,000 against ¥282,859,000 a year ago. Net loss was ¥296,682,000 against ¥282,859,000 a year ago. Net loss per share was ¥3.36 against ¥3.24 per share a year ago. For the year, the company expects net sales of ¥2,000 million. Operating loss was ¥1,800 million. Ordinary loss of ¥1,800 million. Net loss of ¥1,810 million or ¥20.49 per share.

MEDINET Co., Ltd. to Report Q1, 2015 Results on Feb 04, 2015

MEDINET Co., Ltd. announced that they will report Q1, 2015 results at 3:00 PM, Tokyo Standard Time on Feb 04, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
2370:JP ¥239.00 JPY -2.00

2370 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 2370.
View Industry Companies
 

Industry Analysis

2370

Industry Average

Valuation 2370 Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 12.2x
Price/Book 2.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 8.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDINET CO LTD, please visit www.medinet-inc.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.